Αποτελέσματα Αναζήτησης
30 Νοε 2023 · In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.
AIM: The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation” provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation.
We provide recommendations for antithrombotic treatment based on net clinical benefit for patients with AF at varying levels of stroke risk and in a number of common clinical scenarios.
The JACC Central Illustration for the ACC/AHA/ACCP/HRS Atrial Fibrillation Guideline focuses on the importance of AF as a disease continuum in the new classification system of AF. This clinician tool focuses on Top 10 Take-Home Message 1 and aims to change clinical practice.
22 Αυγ 2018 · In this section, we appraise and summarize the evidence and give recommendations for the use of antithrombotic therapy in patients undergoing electrical or pharmacologic cardioversion for AF (or atrial flutter). In particular, the option of NOACs in the setting of cardioversion is reviewed.
Reduction of Stroke and Other Thromboembolic Events in Atrial Fibrillation; ATRIA = Anticoagulation and Risk Factors in Atrial Fibrillation; AVERROES = Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment;
29 Αυγ 2020 · For the Supplementary Data which include background information and detailed discussion of the data that have provided the basis for the Guidelines see European Heart Journal online. Click here to access the corresponding chapter in section 41- Atrial fibrillation.
